Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control.
TLDR
In this article, the authors provided updated insights into the key role of mitochondrial quality control (MQC) mechanisms in coronary ECs and microvascular dysfunction in MI, and discussed the option of MQC as a novel therapeutic target to delay, reverse or repair coronary micro-vascular damage in MI.Abstract:
Endothelial cells (ECs) constitute the innermost layer in all blood vessels to maintain the structural integrity and microcirculation function for coronary microvasculature. Impaired endothelial function is demonstrated in various cardiovascular diseases including myocardial infarction (MI), which is featured by reduced myocardial blood flow as a result of epicardial coronary obstruction, thrombogenesis, and inflammation. In this context, understanding the cellular and molecular mechanisms governing the function of coronary ECs is essential for the early diagnosis and optimal treatment of MI. Although ECs contain relatively fewer mitochondria compared with cardiomyocytes, they function as key sensors of environmental and cellular stress, in the regulation of EC viability, structural integrity and function. Mitochondrial quality control (MQC) machineries respond to a broad array of stress stimuli to regulate fission, fusion, mitophagy and biogenesis in mitochondria. Impaired MQC is a cardinal feature of EC injury and dysfunction. Hence, medications modulating MQC mechanisms are considered as promising novel therapeutic options in MI. Here in this review, we provide updated insights into the key role of MQC mechanisms in coronary ECs and microvascular dysfunction in MI. We also discussed the option of MQC as a novel therapeutic target to delay, reverse or repair coronary microvascular damage in MI. Contemporary available MQC-targeted therapies with potential clinical benefits to alleviate coronary microvascular injury during MI are also summarized.read more
Citations
More filters
Journal ArticleDOI
Mitophagy coordinates the mitochondrial unfolded protein response to attenuate inflammation-mediated myocardial injury.
TL;DR: In this paper, the authors showed that mitophagy and the mitochondrial unfolded protein response (UPRmt) are the predominant stress-responsive and protective mechanisms involved in repairing damaged mitochondria in sepsis-induced myocardial injury.
Journal ArticleDOI
DEHP-induced mitophagy and mitochondrial damage in the heart are associated with dysregulated mitochondrial biogenesis.
TL;DR: In this paper , the authors investigated the mechanism by which di(2-ethylhexyl) phthalate (DEHP) causes heart damage in quail and showed that DEHP-induced mitophagy and mitochondrial damage are associated with the dysregulation of mitochondrial biogenesis.
Journal ArticleDOI
Tetramethylpyrazine: A review on its mechanisms and functions.
TL;DR: Wang et al. as mentioned in this paper reviewed the signal-regulation mechanism of Tetramethylpyrazine (TMP) and showed that TMP has many physiological functions, including antioxidant, anti-inflammatory, and anti-apoptosis properties; autophagy regulation; vasodilation; angiogenesis regulation; mitochondrial damage suppression; endothelial protection; reduction of proliferation and migration of vascular smooth muscle cells.
Journal ArticleDOI
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
C Cai,Zhongzhou Guo,Xing Chang,Ziying Li,Feng Wu,Jing He,Tiantian Cao,Kangrong Wang,Nengxian Shi,Hao Zhou,Sam Toan,David Muid,Yi-Peng Tan +12 more
TL;DR: In this paper , empagliflozin could reduce cardiac microvascular ischemia/reperfusion (I/R) injury by enhancing mitophagy in mice.
References
More filters
Journal ArticleDOI
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
Salim Yusuf,Zhao F,Shamir R. Mehta,Susan Chrolavicius,Gianni Tognoni,K K Fox,Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators +6 more
TL;DR: The antiplatelet agent clopidogrel has beneficial effects in patients with acute coronary syndromes without ST-segment elevation, however, the risk of major bleeding is increased among patients treated with clopIDogrel.
Journal ArticleDOI
Oxygen-derived free radicals in postischemic tissue injury.
TL;DR: It is now clear that oxygen-derived free radicals play an important part in several models of experimentally induced reperfusion injury, and Dysfunction induced by free radicals may be a major component of ischemic diseases of the heart, bowel, liver, kidney, and brain.
Journal ArticleDOI
Role of Endothelial Dysfunction in Atherosclerosis
Jean Davignon,Peter Ganz +1 more
TL;DR: Clinical trials have shown that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) improve endothelial dysfunction in patients with coronary risk factors beyond what could be attributed to their impact on plasma lipids.
Journal ArticleDOI
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.
Zhi-Qing Zhao,Joel S. Corvera,Michael E. Halkos,Faraz Kerendi,Ning-Ping Wang,Robert A. Guyton,Jakob Vinten-Johansen +6 more
TL;DR: It is suggested that Post-con is as effective as Pre-con in reducing infarct size and preserving endothelial function, and may be clinically applicable in coronary interventions, coronary artery bypass surgery, organ transplantation, and peripheral revascularization where reperfusion injury is expressed.
Journal ArticleDOI
The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the Dog
TL;DR: Results suggest that 40 minutes of ischemia were tolerated by the capillary bed of the dog heart without serious capillary damage or perfusion defects, but that 90 min of ischemic injury was associated with the "no-reflow" phenomenon, i.e., failure to achieve uniform reperfusion.